Acute Myca. treatment induces tumor cell softness, reduction in early signaling markers, and a loss of actin foci and WASP activation in tumor-CTL synapses.
(A) Schematic of the pre-treatment of B16 cells with DMSO or 1µM Mycalolide A (Myca) in B16-CTL co-culture assays. (B) AFM setup for B16 stiffness measurements. (C) comparison of DMSO (control) or Myca.-treated B16 stiffness. Each bar in the plot represents the value obtained from a single cell, the p-value of the distributions is <0 .00001, as determined using Mann-Whitney two-tailed test. (D-G) Effects of Myca treatment on events at the B16-CTL synapses. Cells were fixed after 5 min for confocal imaging (D-F) or cultured for 4 h followed by assessment of target cell killing by Sytox staining (G). Images in (D) and (F) show the maximum intensity projected en-face view of F-actin in the CTL/target interfaces. The actin foci are demarcated in white dotted circles (D, left panel), or arrows (F, left panel). The graphs show quantification of F-actin foci (D), phospho-CD3ζ and Zap70 (E), and phospho-WASP (F). Each point in the scatter plot represents the values obtained from individual cells; the bars show Mean± SEM. These experiments were repeated at least thrice with similar results. (G) In vitro killing of B16F10 target cells as a function of Effector: Target (E: T) ratio. Each data point represents values obtained from four independent samples as Mean ± SEM. This experiment was repeated twice with similar results. Scale bar in the images, 5µm.